Tapley Holland, PhD

Tapley Holland is an innovator and entrepreneur in regenerative medicine and the founder and CEO of TruDOSE™, a personalized platelet therapy platform designed to bring precision and individualized dosing to regenerative care. With more than 15 years of experience in the field, Holland recognized the limitations of one-size-fits-all treatment models and developed TruDOSE™’s patented intelligent software technology to deliver patient-specific platelet therapies tailored to individual biology. His work has helped advance new approaches to chronic inflammatory, neurological, autoimmune, and complex health conditions, including Lyme disease and traumatic brain injury. Through research, education, and collaboration with integrative and regenerative medicine practitioners worldwide, Holland continues to advocate for innovative, personalized healing solutions focused on restoring the body’s natural regenerative capacity.